These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36477080)

  • 1. Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption.
    Vit G; Hirth A; Neugebauer N; Kraft BN; Sigismondo G; Cazzola A; Tessmer C; Duro J; Krijgsveld J; Hofmann I; Berger M; Klüter H; Niehrs C; Nilsson J; Krämer A
    Cell Death Discov; 2022 Dec; 8(1):484. PubMed ID: 36477080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
    Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
    Front Immunol; 2022; 13():922138. PubMed ID: 36090985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity.
    Wu YJ; Chiao CC; Chuang PK; Hsieh CB; Ko CY; Ko CC; Chang CF; Chen TY; Nguyen NUN; Hsu CC; Chu TH; Fang CC; Tsai HY; Tsai HC; Anuraga G; Ta HDK; Xuan DTM; Kumar S; Dey S; Wulandari FS; Manalu RT; Ly NP; Wang CY; Lee YK
    Int J Med Sci; 2024; 21(12):2348-2364. PubMed ID: 39310264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
    Katsoulidis E; Mavrommatis E; Woodard J; Shields MA; Sassano A; Carayol N; Sawicki KT; Munshi HG; Platanias LC
    J Biol Chem; 2010 Dec; 285(51):40333-41. PubMed ID: 20956525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.
    Puck A; Aigner R; Modak M; Cejka P; Blaas D; Stöckl J
    Results Immunol; 2015; 5():23-32. PubMed ID: 26623250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crucial role of single-stranded DNA binding in enhancing sensitivity to DNA-damaging agents for Schlafen 11 and Schlafen 13.
    Fujiwara K; Maekawa M; Iimori Y; Ogawa A; Urano T; Kono N; Takeda H; Higashiyama S; Arita M; Murai J
    iScience; 2023 Dec; 26(12):108529. PubMed ID: 38125019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Schlafen 5 (SLFN5) Is a Regulator of Motility and Invasiveness of Renal Cell Carcinoma Cells.
    Sassano A; Mavrommatis E; Arslan AD; Kroczynska B; Beauchamp EM; Khuon S; Chew TL; Green KJ; Munshi HG; Verma AK; Platanias LC
    Mol Cell Biol; 2015 Aug; 35(15):2684-98. PubMed ID: 26012550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schlafen 5 suppresses human immunodeficiency virus type 1 transcription by commandeering cellular epigenetic machinery.
    Ding J; Wang S; Wang Z; Chen S; Zhao J; Solomon M; Liu Z; Guo F; Ma L; Wen J; Li X; Liang C; Cen S
    Nucleic Acids Res; 2022 Jun; 50(11):6137-6153. PubMed ID: 35687115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural, molecular, and functional insights into Schlafen proteins.
    Jo U; Pommier Y
    Exp Mol Med; 2022 Jun; 54(6):730-738. PubMed ID: 35768579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.
    Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL
    J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.
    Arslan AD; Sassano A; Saleiro D; Lisowski P; Kosciuczuk EM; Fischietti M; Eckerdt F; Fish EN; Platanias LC
    Oncogene; 2017 Oct; 36(43):6006-6019. PubMed ID: 28671669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Schlafen 5 regulates reversible epithelial and mesenchymal transitions in breast cancer by suppression of ZEB1 transcription.
    Wan G; Zhu J; Gu X; Yang Y; Liu Y; Wang Z; Zhao Y; Wu H; Huang G; Lu C
    Br J Cancer; 2020 Aug; 123(4):633-643. PubMed ID: 32488136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of SLFN5 induced the epithelial-mesenchymal transition in human lung cancer cell line A549 through β-catenin/Snail/E-cadherin pathway.
    Guo L; Liu Z; Tang X
    Eur J Pharmacol; 2019 Nov; 862():172630. PubMed ID: 31472120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the G2/M transition in oocytes of xenopus tropicalis.
    Stanford JS; Lieberman SL; Wong VL; Ruderman JV
    Dev Biol; 2003 Aug; 260(2):438-48. PubMed ID: 12921744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Noncoding RNA MEG3 Retains Epithelial-Mesenchymal Transition by Sponging miR-146b-5p to Regulate SLFN5 Expression in Breast Cancer Cells.
    Gu X; Li J; Zuo X; Chen K; Wan G; Deng LL; Zhao W; Lu C
    J Immunol Res; 2022; 2022():1824166. PubMed ID: 36033389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer.
    Gu X; Wan G; Yang Y; Liu Y; Yang X; Zheng Y; Jiang L; Zhang P; Liu D; Zhao W; Huang G; Lu C
    Am J Cancer Res; 2020; 10(9):2832-2850. PubMed ID: 33042620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation.
    Li J; Chen Z; Jin M; Gu X; Wang Y; Huang G; Zhao W; Lu C
    Cell Signal; 2024 Dec; 124():111468. PubMed ID: 39395526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway.
    Wan G; Liu Y; Zhu J; Guo L; Li C; Yang Y; Gu X; Deng LL; Lu C
    Cell Signal; 2019 Jul; 59():1-12. PubMed ID: 30844429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in investigating the relationship between Schlafen5 genes and malignant tumors.
    Tu T; Yuan Y; Liu X; Liang X; Yang X; Yang Y
    Front Oncol; 2023; 13():1248825. PubMed ID: 37771431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
    Mavrommatis E; Arslan AD; Sassano A; Hua Y; Kroczynska B; Platanias LC
    J Biol Chem; 2013 Nov; 288(46):33006-15. PubMed ID: 24089532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.